OMX Ventures

OMX Ventures OMX Ventures invests at the intersection of biology, big data, and AI. what they call the "new era of bioengineering." With 45 investments focused on seed and Series A, they've had one IPO (TARA Biosystems), two acquisitions (Finch Therapeutics, Sestina Bio), and built a portfolio spanning genome engineering, cellular programming, and novel bio-tools. Check sizes range from $500K to $15M with a sweet spot around $7.8M, covering both Europe and North America. The portfolio reveals a